| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/24/1997 | CA2240461A1 Cosmetic self-tanning agent having a sunscreen effect |
| 07/24/1997 | CA2240199A1 Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms |
| 07/24/1997 | CA2240075A1 Novel benzoylguanidine derivatives, process for their preparation and their use in the preparation of medicines |
| 07/24/1997 | CA2236684A1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 07/24/1997 | CA2234680A1 Product for inhibition of attachment of h. influenzae to human cells |
| 07/24/1997 | CA2216600A1 Substances extracted from dictyotales, preparation method therefor, and compositions containing same |
| 07/23/1997 | EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785254A2 Phosphatidyl-ionsitol glycan class F (PIG-F), the cDNA encoding it and their use as medicament |
| 07/23/1997 | EP0785252A1 Antisense oligonucleotides against the alpha regulatory subunit of the cAMP dependent-protein kinase for treatment of cancer |
| 07/23/1997 | EP0785212A1 New 19-nor-pregnene derivatives |
| 07/23/1997 | EP0785201A1 Heterodatom containing cyclopentanopyridyl-Oxazolidinones |
| 07/23/1997 | EP0785200A2 Pyridoannelated thienyl and furamyl-oxazolidinones |
| 07/23/1997 | EP0785197A2 2-oxo and 2-thio-1,2-dihydroquinolinyl-oxazolidinones |
| 07/23/1997 | EP0785196A1 Polymorphs a and b of 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl) propyl]piperazine |
| 07/23/1997 | EP0785195A1 Piperidine or tetrahydropyridine derivatives having affinity for the serotonin 5-HTIA receptor |
| 07/23/1997 | EP0785191A1 Fused indan derivatives and salts thereof |
| 07/23/1997 | EP0785190A2 Quinolinone derivative and antiallergic agent with said quinolinone derivative as the active ingredient |
| 07/23/1997 | EP0784983A2 Use of extracellular hemoglobin |
| 07/23/1997 | EP0784982A2 Obesity protein formulations |
| 07/23/1997 | EP0784981A2 Obesity protein formulations |
| 07/23/1997 | EP0784979A2 Obesity protein formulations |
| 07/23/1997 | EP0784977A1 Use of low molecular weight dermatan sulfate for the manufacture of a medicament for the prevention and therapy of the pulmonary embolism |
| 07/23/1997 | EP0784976A1 Immunosuppressive-activity potentiating compositions containing ascorbyl tocopheryl phosphoric acid diesters |
| 07/23/1997 | EP0784975A1 Use of acetylsalicylic acid in the manufacture of a drug for the treatment of skin injuries |
| 07/23/1997 | EP0784973A2 Quinoxaline derivatives for treating tinnitus |
| 07/23/1997 | EP0784692A1 Attenuated viruses and method of making the same |
| 07/23/1997 | EP0784679A1 Cancer treatment by expression of differentiation factor receptor |
| 07/23/1997 | EP0784629A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 07/23/1997 | EP0784628A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 07/23/1997 | EP0784627A1 Process for preparing 17-beta-substituted-androsta-3,5-dien-3-carboxylic acids |
| 07/23/1997 | EP0784624A1 Purine and guanine compounds as inhibitors of pnp |
| 07/23/1997 | EP0784623A1 Naphthyridine derivatives |
| 07/23/1997 | EP0784622A1 Naphthyridinone derivatives |
| 07/23/1997 | EP0784620A1 N-substituted piperidinyl bicyclic benzoate derivatives |
| 07/23/1997 | EP0784619A1 Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives |
| 07/23/1997 | EP0784613A1 Colchicine derivatives and the therapeutical use thereof |
| 07/23/1997 | EP0784612A1 Urea derivatives and their use as acat-inhibitors |
| 07/23/1997 | EP0784604A1 Processes for the preparation of (e)-2-fluoromethylene-4-(4-fluorophenyl) butylamine and alkali metal salts of diformylamide |
| 07/23/1997 | EP0784489A2 Composition use of nucleoside analogues and gene transfection for tissue imaging and therapy |
| 07/23/1997 | EP0784476A1 Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and possibly a vitamin b 12? compound |
| 07/23/1997 | EP0784475A1 Prostagladin analogues by the oral or vaginal route for the routine management of the third stage of labour |
| 07/23/1997 | EP0784474A2 Parenteral pharmaceutical compositions containing gf120918a |
| 07/23/1997 | EP0784473A1 Inhibitors of farnesyl-protein transferase |
| 07/23/1997 | EP0784472A1 Agent for treating papilloma virus-positive malignant and premalignant lesions |
| 07/23/1997 | EP0784470A1 Liposome-formulations for treatment of viral diseases |
| 07/23/1997 | EP0784469A1 Compositions for the delivery of antigens |
| 07/23/1997 | EP0784430A1 Method for reducing unwanted cellular adhesions |
| 07/23/1997 | EP0784429A1 Method and formulation of stimulating nitric oxide synthesis |
| 07/23/1997 | EP0675895B1 Etoposide derivatives, process for their preparation, their use as a drug and in the preparation of a drug for treating cancer |
| 07/23/1997 | EP0649464B1 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/23/1997 | EP0648117B1 Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances |
| 07/23/1997 | EP0641768B1 Nitroxyalkylamide derivative |
| 07/23/1997 | EP0641236B1 A method for coated particles in a spray-drying plant |
| 07/23/1997 | EP0637957B1 Use of an emulsion containing omega-3 fatty acids to produce a medicament to be parenterally administered for treating inflammatory diseases |
| 07/23/1997 | EP0630229B1 Pressurized gas packagings using polyoxyethylene glyceryl-obates |
| 07/23/1997 | EP0599914B1 Pharmacologically enhanced formulations |
| 07/23/1997 | EP0581797B1 Novel thiophene-2-carboxylic acid derivatives and process for their production |
| 07/23/1997 | EP0554400B1 Retroviral protease inhibitors |
| 07/23/1997 | EP0540717B1 UNSATURATED 17$g(b)-SUBSTITUTED 3-CARBOXY STEROIDS |
| 07/23/1997 | EP0539575B1 Inhibition of metastasis in patients having cancer with pyridyloxazole-2-ones |
| 07/23/1997 | EP0538332B1 Polycyclic guanine derivatives |
| 07/23/1997 | EP0532530B1 Derivatives of 6-aminooctahydroindolizinetriol |
| 07/23/1997 | EP0531341B1 Use of leukoregulin for the treatment of animals infected with an envelope-virus |
| 07/23/1997 | EP0451194B1 Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 07/23/1997 | CN1155287A Cross-linked polymers for removing bile salts from patient |
| 07/23/1997 | CN1155285A New 3-substituted 3H-2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 07/23/1997 | CN1155284A Thipyridines for use in control of helicobacter bacteria |
| 07/23/1997 | CN1155281A Noval pyrimidine derivatives and prepn. processes thereof |
| 07/23/1997 | CN1155279A Neuroprotective 3-(piperidinyl-1)-chroman-4,7,-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkane alcohol |
| 07/23/1997 | CN1155278A Arylthio compounds as antibacteral and antiviral agents |
| 07/23/1997 | CN1155276A Enzyme inhibitors |
| 07/23/1997 | CN1155274A New salts of 2-£(2,6-dichlorophenyl)amine| phenylacetoxyacetic acid with organic basic cations |
| 07/23/1997 | CN1155247A Aqueous risperidone formulations |
| 07/23/1997 | CN1155245A Use of muramyl peptide compounds |
| 07/23/1997 | CN1155244A Triazine derivative and medicine |
| 07/23/1997 | CN1155243A Method of preventing and treating ophthalmic inflammation and/or wound |
| 07/23/1997 | CN1155242A Liquid pharmaceutical composition for controlled release of moguisteine |
| 07/23/1997 | CN1155241A Use of selegilin in the treatment of epilectic conditions |
| 07/23/1997 | CN1155240A Use of sophorolipids and cosmetic and dermatological compositions |
| 07/23/1997 | CN1154856A Natural freckle-diminishing face-beautifying product and peparation method thereof |
| 07/23/1997 | CN1154843A Diversine hydrochloride composition and its usage for preventing and treating retinitis pigmentosa |
| 07/23/1997 | CN1154842A Skin-penetrating absorption prepration |
| 07/23/1997 | CN1154841A Releasing tablet of insoral hydrochloride |
| 07/23/1997 | CN1154840A Oral medicinal liquor for abstaining from taking drug and production technology thereof |
| 07/23/1997 | CN1154838A Aerosol for health-care of oral cavity |
| 07/23/1997 | CN1035468C Prepn. of injectable veterinary composition free from toxic side effects |
| 07/22/1997 | US5650541 Ethacrynic acid-like compounds and use thereof to treat glaucoma |
| 07/22/1997 | US5650538 Organic salts of N,N'-diacetyl cystine |
| 07/22/1997 | US5650524 Salt formation with tartaric acid and forming a clear solution |
| 07/22/1997 | US5650523 Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one |
| 07/22/1997 | US5650521 Pyrrolidine derivatives |
| 07/22/1997 | US5650502 Ribozyme analogs having rigid non-nucleotidic linkers |
| 07/22/1997 | US5650486 Monomeric insulin analog formulations |
| 07/22/1997 | US5650447 Nitric oxide-releasing polymers to treat restenosis and related disorders |
| 07/22/1997 | US5650445 3,4-diphenyl-3-hexene |
| 07/22/1997 | US5650444 Bronchodilator agents, antiallergens and antiinflammatory agents |
| 07/22/1997 | US5650443 Method of treatment of parkinson's disease |
| 07/22/1997 | US5650442 Use of nitric oxide releasing compounds as hypoxic cell radiation sensitizers |
| 07/22/1997 | US5650441 Method of assaying CD4 glycoproteins by using certain azo dyes |
| 07/22/1997 | US5650440 Method of using citramalic acid for treating wrinkles |